NCT01809262View on ClinicalTrials.gov

Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

single dose of 5 mcg

solution for inhalation

DRUG

single dose of placebo

solution for inhalation

DRUG

single dose of 40 mcg

solution for inhalation

DRUG

single dose of 20 mcg

solution for inhalation

DRUG

single dose of 2 mcg

solution for inhalation

DRUG

single dose of 10 mcg

solution for inhalation

Trial Locations (1)

Unknown

1222.3.1 Atrium medisch centrum, Heerlen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY